Detalhe da pesquisa
1.
Chronic fatigue in long-term survivors of Hodgkin's lymphoma after contemporary risk-adapted treatment.
Acta Oncol
; 62(1): 80-88, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36715320
2.
Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin's lymphoma; symptom burden and quality of life.
Acta Oncol
; 60(7): 911-920, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33905285
3.
Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma.
Acta Oncol
; 58(9): 1315-1322, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31286808
4.
Brentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011-2016.
Acta Oncol
; 59(1): 101-105, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31429371
5.
Work ability and work status changes in long-term Hodgkin lymphoma survivors with focus on late adverse effects.
J Cancer Surviv
; 2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37526861